Beta blockers and drug oxidation status.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D010084:Oxidation-Reduction
D000319:Adrenergic beta-Antagonists